Boostrix
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
BACKGROUND
We estimated the vaccine effectiveness (VE) of tetanus-diphtheria-acellular pertussis vaccine (Tdap) for preventing…
SummaryAbstractBoostrix® is a three-pertussis component, combined, reduced-antigen content tetanus, diphtheria, and acellular…
On July 8, 2011, the Food and Drug Administration (FDA) approved an expanded age indication for the tetanus toxoid, reduced…
OBJECTIVE
In order to search the preparation process and optimazing dosage ratio of adsorbed diphtheria-tetanus-acellular…
Pertussis continues to circulate in Chinese communities and older children, adolescents and adults are sources of infection for…
Pertussis remains a serious problem in many countries. Even in countries with high vaccine coverage and a long vaccination…
On December 4, 2008, the Food and Drug Administration (FDA) approved an expanded age indication for the tetanus toxoid, reduced…
GlaxoSmithKline plc has developed and launched Boostrix, a subunit vaccine for use in adolescents and adults as a booster…